Company
Summit Therapeutics Inc. (SMMT)
Standardized SEC financial data for Summit Therapeutics Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001599298 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-163.9%
Free cash flow
-$323.6M
Current ratio
9.87×
EPS (diluted)
$-1.44
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.8M | $705K | $0 | — | $0 | — |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $66.4M | $71.8M | $648.6M | $186.2M | $105.2M | $225.6M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$48.1M | -$72.6M | -$41.6M | -$76.8M | -$142.1M | -$322.9M |
| Capital expenditures |
Get SMMT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/SMMT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/SMMT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"